WASHINGTON DC – A major federal shift in marijuana policy is underway—but for Michigan’s booming cannabis industry, the impact is more nuanced than headlines suggest.

The Trump administration announced Thursday it is moving to reclassify marijuana from a Schedule I drug to Schedule III under the Drug Enforcement Administration framework—formally recognizing medical value for the first time in decades.

That’s significant.

But it does not legalize cannabis federally, and it does not directly apply to recreational marijuana markets like Michigan’s $3 billion adult-use industry.

What Actually Changes

The biggest impact comes from taxes.

Under current law, cannabis businesses are subject to IRS Section 280E, which prevents companies trafficking in Schedule I or II substances from deducting ordinary business expenses.

A major federal shift in marijuana policy is underway—but for Michigan’s booming cannabis industry, the impact is more nuanced than headlines suggest.

The Trump administration is moving to reclassify marijuana from a Schedule I drug to Schedule III under the Drug Enforcement Administration framework—formally recognizing medical value for the first time in decades.

That’s significant.

But it does not legalize cannabis federally, and it does not directly apply to recreational marijuana markets like Michigan’s $3 billion adult-use industry.

What Actually Changes

The biggest impact comes from taxes.

Under current law, cannabis businesses are subject to IRS Section 280E, which prevents companies trafficking in Schedule I or II substances from deducting ordinary business expenses.

For Michigan operators—especially large multi-state operators and vertically integrated companies—that could mean:

  • Lower effective tax rates
  • Improved profitability
  • More capital available for expansion and hiring

In short, cannabis businesses begin to look more like normal businesses on paper.

What Doesn’t Change

Beyond tax relief, the impact is far more limited.

According to a legal analysis by Reuters, recreational cannabis operators are expected to see “limited operational changes” under rescheduling. The same analysis makes clear that the move does not legalize marijuana federally or create a national commercial framework.

A second Reuters analysis adds that the effects on recreational markets remain uncertain beyond tax implications.

That distinction is critical in Michigan, where adult-use cannabis dominates the market and medical marijuana sales now represent only a small fraction of total revenue.

Key limitations remain:

  • Cannabis is still federally illegal
  • Interstate commerce is still prohibited
  • Dispensaries remain state-regulated businesses
  • No pathway exists for national retail expansion

For consumers, nothing changes at the counter.

Banking Still Stuck in Neutral

One of the biggest questions is whether rescheduling opens the door to traditional banking.

The answer: not yet.

Even under Schedule III, cannabis remains a controlled substance, and recreational cannabis remains federally illegal. That keeps banks subject to anti-money laundering laws and federal regulatory scrutiny.

Large federally chartered institutions—including JPMorgan Chase, Bank of America, and Wells Fargo—are unlikely to move aggressively without additional legal protections.

Industry analysts expect:

  • Incremental expansion by smaller banks and credit unions
  • Continued caution from major financial institutions
  • No immediate flood of capital into the sector

In practical terms, cannabis remains a partially banked, high-friction industry.

Why the SAFER Banking Act Still Matters

The clearest path to full financial normalization remains the SAFER Banking Act.

The legislation would provide a federal safe harbor, preventing regulators from penalizing banks that serve state-legal cannabis businesses. That would unlock:

  • Full checking and lending services
  • Credit card processing
  • Reduced reliance on cash

The bill has bipartisan support and has passed the House multiple times, but it has repeatedly stalled in the Senate. While a version advanced through the Senate Banking Committee, it has yet to receive a full floor vote.

Until that changes, large financial institutions are expected to stay on the sidelines—even with rescheduling.

At the Checkout Counter: A Workaround Economy

That disconnect is most visible at the checkout counter.

Despite years of legalization, many Michigan dispensaries still operate in a patchwork payments environment. So-called “cashless ATM” systems remain common, allowing customers to use a card—but only by rounding transactions up, often to the nearest $5, and returning change.

It works—but it’s inefficient.

Bill Shaw, managing partner of Genus Credit Services, said newer PIN-based debit systems aim to streamline the process. His company offers this payment system to cannabis provisioning centers.

“Instead of rounding transactions, customers can pay the exact amount directly from their bank account using a PIN-based system,” Shaw said. “It cuts transaction time down to seconds and removes the need for cash handling or making change at the register.”

Shaw said some systems also shift transaction fees to the customer rather than the retailer and may offer small revenue-sharing opportunities for dispensaries.

For Michigan’s cannabis industry, the federal shift is meaningful—but narrow.

  • ✔️ Major tax relief likely
  • ✔️ Improved perception and investment potential
  • ❌ No federal legalization
  • ❌ No interstate commerce
  • ❌ No full banking access

In a state where recreational cannabis drives billions in annual sales, the benefits are real—but they are largely financial, not structural.

Until Congress acts on banking reform or broader legalization, the industry will continue to operate in a hybrid reality: legal at the state level, restricted at the federal level, and reliant on workarounds to function day to day.

Disclosure: The author is working with Bill Shaw on a separate business initiative related to cannabis payment systems.